Inhibition of protein kinase CKII activity by euchrestaflavanone B purified from Cudrania tricuspidata

Oncology Research

Volumn 15, Issue 6, 2005, Pages 327-332

  Kim, Soon Hee ^a   Yoon, Soo Hyun ^a   Lee, Byong Won ^b   Park, Ki Hun ^b   Kim, Young Ho ^a   Bae, Young Seuk ^a  

^a Kyungpook National University   (South Korea)

^b Gyeongsang National University   (South Korea)

Author keywords

Anticancer drug; Apoptosis; Enzyme inhibitor; Euchrestaflavanone B; Protein kinase CKII

Indexed keywords

CASEIN KINASE II; ENZYME INHIBITOR; EUCHRESTAFLAVANONE B; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PLANT EXTRACT; PROCASPASE 3; PROTEIN KINASE INHIBITOR; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; BARK; CANCER CELL; CANCER INHIBITION; CELL DEATH; CHEMICAL STRUCTURE; CUDRANIA TRICUSPIDATA; CYTOTOXICITY; DRUG ISOLATION; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME INHIBITION; ENZYME PURIFICATION; HUMAN; HUMAN CELL; KOREA; MEDICINAL PLANT; NONHUMAN; PLANT ROOT; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; TREE; WESTERN BLOTTING; WOODY STEM;

EID: 30444450686     PISSN: 09650407     EISSN: None     Source Type: Journal    
DOI: 10.3727/096504005776404562     Document Type: Article

References (17)

1. Issinger, O.-G. Casein kinases: Pleiotropic mediators of cellular regulation. Pharmacol. Ther. 59:1-30; 1993.
2. Pinna, L. A. Protein kinase CK2. Int. J. Biochem. Cell Biol. 29:551-554; 1997.
3. Litchfield, D. W. Protein kinase CK2: Structure, regulation and role in cellular decisions of life and death. Biochem. J. 369:1-15; 2002.
4. Padmanabha, R.; Chen-Wu, J. L.-P.; Hanna, D. E.; Glover, C. V. C. Isolation, sequencing, and disruption of the yeast CKA2 gene: Casein kinase II is essential for viability in Saccharomyces cerevisiae. Mol. Cell. Biol. 10: 4089-4099; 1990.
5. Hanna, D. E.; Rethinaswamy, A.; Glover, C. V. C. Casein kinase II is required for cell cycle progression during G1 and G2/M in Saccharomyces cerevisiae. J. Biol. Chem. 270:25905-25914; 1995.
6. Münstermann, U.; Fritz, G.; Seitz, G.; Lu, Y. P.; Schneider, H. R.; Issinger, O. G. Casein kinase II is elevated in solid human tumours and rapidly proliferating non-neoplastic tissue. Eur. J. Biochem. 189:251-257; 1990.
7. Daya-Makin, M.; Sanghera, J. S.; Mogentale, T. L.; Lipp, M.; Parchomchuk, J.; Hogg, J. C.; Pelech, S. L. Activation of a tumor-associated protein kinase (p40TAK) and casein kinase 2 in human squamous cell carcinomas and adenocarcinomas of the lung. Cancer Res. 54:2262-2268; 1994.
8. Faust, R. A.; Gapany, M.; Tristani, P.; Davis, A.; Adams, G. L.; Ahmed, K. Elevated protein kinase CK2 activity in chromatin of head and neck tumors: Association with malignant transformation. Cancer Lett. 101:31-35; 1996.
9. Seldin, D. C.; Leder, P. Casein kinase IIα transgene-induced murine lymphoma: Relation to theileriosis in cattle. Science 267:894-897; 1995.
10. The dictionary of Chinese drugs, vol. 2. Shougakukan, Tokyo: Shanghai Science and Technological Publisher; 1985.
11. Ding, G. M.; Hua, H. Q.; Zhou, C. X. In: Zhang, M. Q., Gong, H. M., eds. Clinical application of antitumor traditional Chinese medicines. Beijing: People's Medical Publishing House; 1998:286-295.
12. Kim, M.-S.; Lee, Y.-T.; Kim, J.-M.; Cha, J.-Y.; Bae, Y.-S. Characterization of protein interaction among subunits of protein kinase CKII in vivo and in vitro. Mol. Cell 8:43-48; 1998.
13. Mosmann, T. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J. Immunol. Methods 65:55-63; 1983.
14. Kuenzel, E. A.; Krebs, E. G. A synthetic peptide substrate specific for casein kinase II. Proc. Natl. Acad. Sci. USA 82:737-741; 1985.
15. Tewari, M.; Quan, L. T.; O'Rourke, K.; Desnoyers, S.; Zeng, Z.; Beidler, D. R.; Poirier, G. G.; Salvesen, G. S.; Dixit, V. M. Yama/CPP32β, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase. Cell 81: 801-809; 1995.
16. te Poele, R. H.; Okorokov, A. L.; Joel, S. P. RNA synthesis block by 5,6-dichloro-1-β-D-ribofuranosylbenzimidazole (DRB) triggers p53-dependent apoptosis in human colon carcinoma cells. Oncogene 18:5765-5772; 1999.
17. Ruzzene, M.; Penzo, D.; Pinna, L. A. Protein kinase CK2 inhibitor 4,5,6,7-tetrabromobenzotriazole (TBB) induces apoptosis and caspase-dependent degradation of haematopoietic lineage cell-specific protein 1 (HS1) in Jurkat cells. Biochem. J. 364:41-47; 2002.